Old Web
English
Sign In
Acemap
>
authorDetail
>
Farzana Masood
Farzana Masood
Harvard University
Medicine
Neutropenia
Rituximab
Histone deacetylase inhibitor
Panobinostat
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia
2017
Im Ghobrial
Federico Campigotto
Timothy J. Murphy
Erica N Boswell
Ranjit Banwait
Feda Azab
Stacey Chuma
Janet Kunsman
Amanda Donovan
Farzana Masood
Diane Warren
Scott J. Rodig
Kenneth C. Anderson
Paul G. Richardson
Edie Weller
Jeffrey Matous
Show All
Source
Cite
Save
Citations (0)
Phase I/II Trial Of Everolimus, Bortezomib and Rituximab In Relapsed Or Relapsed/Refractory Waldenstrom's Macroglobulinemia
2013
Blood
Irene M. Ghobrial
Erica N Boswell
Stacey Chuma
Ranjit Banwait
Courtney Hanlon
Houry Leblebjian
Diane Warren
Patrick Mostyn
Farzana Masood
Paul G. Richardson
Steven P. Treon
Jeffrey Matous
Show All
Source
Cite
Save
Citations (6)
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia
2013
Blood
Irene M. Ghobrial
Federico Campigotto
Timothy J. Murphy
Erica N Boswell
Ranjit Banwait
Feda Azab
Stacey Chuma
Janet Kunsman
Amanda Donovan
Farzana Masood
Diane Warren
Scott J. Rodig
Kenneth C. Anderson
Paul G. Richardson
Edie Weller
Jeffrey Matous
Show All
Source
Cite
Save
Citations (46)
1